MEK Inhibitor News and Research

RSS
Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows

Pretreatment improves outcomes in high-risk stage 3 melanoma, study shows

Treatment for skin cancer could be more effective if combined with arthritis drug

Treatment for skin cancer could be more effective if combined with arthritis drug

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination therapy found to be effective adjuvant treatment option in melanoma patients

Combination therapy shows potential for effective treatment of RAS-mutant cancers

Combination therapy shows potential for effective treatment of RAS-mutant cancers

KRAS ‘imbalances’ that emerge over time may influence cancer treatment response

KRAS ‘imbalances’ that emerge over time may influence cancer treatment response

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Scientists discover how MEK inhibitor boosts antitumor activity and slows cancer progression

Researchers identify existing drugs that appear to prevent aggressive subtype of pediatric brain tumors

Researchers identify existing drugs that appear to prevent aggressive subtype of pediatric brain tumors

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Researcher identifies mechanisms that may cause resistance to BRAF inhibitor

Researcher identifies mechanisms that may cause resistance to BRAF inhibitor

Breakthrough in cancer cell screening advances personalised treatment of childhood leukaemia

Breakthrough in cancer cell screening advances personalised treatment of childhood leukaemia

Targeted therapies suppress T cell activity that could actually help fight tumors

Targeted therapies suppress T cell activity that could actually help fight tumors

Wistar Institute scientists use revolutionary method to block melanoma progression

Wistar Institute scientists use revolutionary method to block melanoma progression

CU Cancer Center study reports 'robust antitumor activity' of TAK-733 drug in mouse models of colorectal cancer

CU Cancer Center study reports 'robust antitumor activity' of TAK-733 drug in mouse models of colorectal cancer

2-year advanced melanoma survival benefit with dabrafenib, trametinib combination

2-year advanced melanoma survival benefit with dabrafenib, trametinib combination

Clinical trial data from Array BioPharma's binimetinib and encorafenib presented at ECC 2015

Clinical trial data from Array BioPharma's binimetinib and encorafenib presented at ECC 2015

Combination of two targeted therapies increases survival in advanced melanoma

Combination of two targeted therapies increases survival in advanced melanoma

Aeterna Zentaris selects optimized Erk inhibitor molecule for further development

Aeterna Zentaris selects optimized Erk inhibitor molecule for further development

Phase 3 SUMIT study: Selumetinib fails to meet primary endpoint in patients with metastatic uveal melanoma

Phase 3 SUMIT study: Selumetinib fails to meet primary endpoint in patients with metastatic uveal melanoma

Study may lead to better treatments for children with neuroblastoma

Study may lead to better treatments for children with neuroblastoma